Volume | 9,358 |
|
|||||
News | - | ||||||
Day High | 5.4068 | Low High |
|||||
Day Low | 5.20 |
Company Name | Stock Ticker Symbol | Market | Type |
---|---|---|---|
Palisade Bio Inc | PALI | NASDAQ | Common Stock |
Open Price | Low Price | High Price | Close Price | Prev Close |
---|---|---|---|---|
5.38 | 5.20 | 5.4068 | 5.41 |
Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
---|---|---|---|---|---|
121 | 9,358 | $ 5.33 | $ 49,876 | - | 3.82 - 36.60 |
Last Trade Time | Type | Quantity | Stock Price | Currency |
---|---|---|---|---|
12:36:24 | 60 | $ 5.255 | USD |
Palisade Bio Inc Financials
Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
---|---|---|---|---|---|---|
20.14M | 12.13M | - | 250k | -12.3M | -1.01 | - |
Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
---|---|---|---|---|---|
- | - | - | - |
Palisade Bio News
Loading Messages....
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical PALI Price Data
Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
---|---|---|---|---|---|---|---|
1 Week | 6.23 | 6.6499 | 5.20 | 6.05 | 39,710 | -0.975 | -15.65% |
1 Month | 5.69 | 9.09 | 5.20 | 7.03 | 724,020 | -0.435 | -7.64% |
3 Months | 6.135 | 9.09 | 3.82 | 6.15 | 1,153,662 | -0.88 | -14.34% |
6 Months | 8.70 | 22.35 | 3.82 | 11.23 | 1,898,739 | -3.45 | -39.60% |
1 Year | 22.50 | 36.60 | 3.82 | 15.52 | 1,771,272 | -17.25 | -76.64% |
3 Years | 2,782.50 | 3,427.50 | 3.82 | 231.21 | 1,976,258 | -2,777.25 | -99.81% |
5 Years | 6,750.00 | 8,182.50 | 3.82 | 346.08 | 1,997,356 | -6,744.75 | -99.92% |
Palisade Bio Description
Palisade Bio Inc is a clinical-stage biopharma company. It is advancing oral therapies that help patients with acute and chronic gastrointestinal complications stemming from post-operative digestive enzyme damage. Palisade Bio's innovative lead asset, LB1148, is a Phase 3-ready protease inhibitor with the potential to both reduce abdominal adhesions and help restore bowel function following surgery. |